| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Clinical Nutrition (L.N., R.V., M.I.J.U.), Medicine (L.N., M.L.), and Physiology (R.R., J.T.), University of Kuopio, and Kuopio Research Institute of Exercise Medicine and Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital (R.R., J.T.), FIN-70211 Kuopio, Finland; Department of Pharmacology and Clinical Pharmacology, University of Turku (M.K.K., M.K., U.P.), FIN-20520 Turku, Finland; and Department of Endocrinology and Metabolism, Merck Research Laboratories, Merck & Co., Inc. (M.M.), Rahway, New Jersey 07065-0900
Address all correspondence and requests for reprints to: Leo Niskanen, M.D., Department of Medicine, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland. E-mail: leo.niskanen{at}kuh.fi
We have recently demonstrated that subjects having Pro7 in the signal peptide of neuropeptide Y (NPY) have higher serum cholesterol and apolipoprotein B levels than individuals with wild-type (Leu7Leu7) signal peptide sequence. We investigated the association of Leu7Pro polymorphism with common carotid intima media thickness (IMT) assessed by ultrasonograph in patients with type 2 diabetes (n = 81; 41 men and 40 women; mean age, 67.1 yr) and nondiabetic subjects (n = 105; 48 men and 57 women; mean age, 65.5 yr) and genotyped for the Leu7Pro polymorphism in prepro-NPY. The frequency of Pro7 in prepro-NPY was 9.9% (8 of 81) in diabetic patients and 14.3% (15 of 105) in control subjects (P = 0.360). The mean common carotid IMT was 1.04 ± 0.02 mm in nondiabetic subjects without the Leu7Pro polymorphism and 1.14 ± 0.04 mm in nondiabetic subjects with in (P = 0.156) and 1.18 ± 0.03 and 1.58 ± 0.21 mm in diabetic patients without and with the Leu7Pro polymorphism (P = 0.004), respectively. In the analysis of covariance of the entire group, the mean common carotid IMT was independently associated with the Leu7Pro polymorphism (F = 5.165; P = 0.024) after adjustment for known risk factors. Thus, the presence of the Pro7 substitution in the prepro-NPY associates with increased carotid atherosclerosis.
This article has been cited by other articles:
![]() |
S. T. Ruohonen, U. Pesonen, N. Moritz, K. Kaipio, M. Roytta, M. Koulu, and E. Savontaus Transgenic Mice Overexpressing Neuropeptide Y in Noradrenergic Neurons: A Novel Model of Increased Adiposity and Impaired Glucose Tolerance Diabetes, June 1, 2008; 57(6): 1517 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ma, S. Nordman, A. Mollsten, H. Falhammar, K. Brismar, G. Dahlquist, S. Efendic, and H. F Gu Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations Eur. J. Endocrinol., November 1, 2007; 157(5): 641 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ribatti, M. T. Conconi, and G. G. Nussdorfer Nonclassic Endogenous Novel Regulators of Angiogenesis Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, A.-C. Jonsson-Rylander, K. Abe, and Z. Zukowska Chronic Stress Induces Rapid Occlusion of Angioplasty-Injured Rat Carotid Artery by Activating Neuropeptide Y and Its Y1 Receptors Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2075 - 2080. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Jaakkola, T. Kuusela, T. Jartti, U. Pesonen, M. Koulu, T. Vahlberg, and J. Kallio The Leu7Pro Polymorphism of PreproNPY Is Associated with Decreased Insulin Secretion, Delayed Ghrelin Suppression, and Increased Cardiovascular Responsiveness to Norepinephrine during Oral Glucose Tolerance Test J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3646 - 3652. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Manolio, E. Boerwinkle, C. J. O'Donnell, and A. F. Wilson Genetics of Ultrasonographic Carotid Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1567 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pettersson-Fernholm, M. K. Karvonen, J. Kallio, C. M. Forsblom, M. Koulu, U. Pesonen, J. A. Fagerudd, and P.-H. Groop Leucine 7 to Proline 7 Polymorphism in the Preproneuropeptide Y Is Associated With Proteinuria, Coronary Heart Disease, and Glycemic Control in Type 1 Diabetic Patients Diabetes Care, February 1, 2004; 27(2): 503 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kallio, U. Pesonen, U. Jaakkola, M. K. Karvonen, H. Helenius, and M. Koulu Changes in Diurnal Sympathoadrenal Balance and Pituitary Hormone Secretion in Subjects with Leu7Pro Polymorphism in the Prepro-Neuropeptide Y J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3278 - 3283. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, E. W. Lee, H. Ji, and Z. Zukowska Neuropeptide Y-Induced Acceleration of Postangioplasty Occlusion of Rat Carotid Artery Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1204 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lappalainen, H. R. Kranzler, R. Malison, L. H. Price, C. Van Dyck, R. A. Rosenheck, J. Cramer, S. Southwick, D. Charney, J. Krystal, et al. A Functional Neuropeptide Y Leu7Pro Polymorphism Associated With Alcohol Dependence in a Large Population Sample From the United States Arch Gen Psychiatry, September 1, 2002; 59(9): 825 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Maeno, H. Koyama, H. Tahara, M. Komatsu, M. Emoto, T. Shoji, M. Inaba, T. Miki, Y. Okuno, and Y. Nishizawa The 807T Allele in {alpha}2 Integrin Is Protective Against Atherosclerotic Arterial Wall Thickening and the Occurrence of Plaque in Patients With Type 2 Diabetes Diabetes, May 1, 2002; 51(5): 1523 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kallio, U. Pesonen, M. K. Karvonen, M. Kojima, H. Hosoda, K. Kangawa, and M. Koulu Enhanced Exercise-Induced GH Secretion in Subjects with Pro7 Substitution in the Prepro-NPY J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5348 - 5352. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |